JW Lifescience Corporation (234080.KS) — Stock Score Summary

JW Lifescience Corporation (234080.KS) has a MoatMap StockRank of 98/100 based on Quality (66/100), Value (84/100), and Momentum (45/100) factor scores. The current signal is STRONG BUY. JW Lifescience specializes in infusion fluids for the Korean domestic market. While stable, it is a low-growth utility-like business with no exposure to the high-margin CDMO pricing power cycle or other high-velocity macro themes.

JW Lifescience Corporation specializes in the development and manufacture of high-quality infusion solutions, including basic IV fluids, nutritional supplements, and specialized therapeutic infusions. The company's competitive moat is sustained by its state-of-the-art, fully automated production facilities and its dominant market share in the Korean non-drinkable fluid market. It is a vertically integrated market leader in South Korea, expanding its global footprint through strategic export partnerships.

Key Financial Metrics

Price$7.30
Market Cap$117M
P/E (TTM)5.78
Price/Book0.75
Return on Equity14.0%
Return on Invested Capital14.8%
Debt/Equity19.32
Gross Margin28.8%
Operating Margin14.7%
Revenue Growth-7.4%
Dividend Yield5.1%
Free Cash Flow$10K

JW Lifescience Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is JW Lifescience Corporation’s (234080.KS) StockRank?
MoatMap’s StockRank for JW Lifescience Corporation (234080.KS) is 98/100, with a Strong Buy signal. It is a composite of Quality (66), Value (84), and Momentum (45) factor ranks across MoatMap’s 19,000+ stock universe.
Does JW Lifescience Corporation have an economic moat?
JW Lifescience Corporation (234080.KS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JW Lifescience Corporation a buy, hold, or sell?
MoatMap’s current signal for JW Lifescience Corporation (234080.KS) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is JW Lifescience Corporation in?
JW Lifescience Corporation (234080.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks234080.KS deep dive reportAI ChampionsHow we score stocksSense-check another stock